FDA Approves Low-Cost Ventilator Developed by U of Minnesota

The U.S. Food and Drug Administration on Wednesday approved a low-cost ventilator developed by the University of Minnesota and aimed at helping COVID-19 patients breathe.

The FDA authorized use of the compact device, known as the Coventor, that was quickly developed and designed by a team of university researchers, a medical school resident and an engineer.

The developers hope the Coventor will be used in clinical settings where traditional ventilators are unavailable.

Read More

Premium Employers